AJP - Heart and Circulatory Physiology, Vol 272, Issue 6 2541-H2546, Copyright © 1997 by American Physiological Society

ARTICLES

Release of nitric oxide and prostaglandin H2 to acetylcholine in skeletal muscle venules

G. Dornyei, G. Kaley and A. Koller
Department of Physiology, New York Medical College, Valhalla 10595, USA.

The role of endothelium in regulating venular resistance is not well characterized. Thus we aimed to elucidate the endothelium-derived factors involved in the mediation of responses of rat gracilis muscle venules to acetylcholine (ACh) and other vasoactive agents. Changes in diameter of perfusion pressure (7.5 mmHg)- and norepinephrine (10(-6) M)-constricted venules (approximately 225 microns in diam) to cumulative doses of ACh (10(-9) to 10(-4) M) and sodium nitroprusside (SNP, 10(-9) to 10(-4) M), before and after endothelium removal or application of various inhibitors, were measured. Lower doses of ACh elicited dilations (up to 42.1 +/- 4.7%), whereas higher doses of ACh resulted in smaller dilations or even constrictions. Endothelium removal abolished both ACh-induced dilation and constriction. In the presence of indomethacin (2.8 x 10(-5) M), a cyclooxygenase blocker, or SQ-29548 (10(-6) M), a thromboxane A2-prostaglandin H2 (PGH2) receptor antagonist, higher doses of ACh caused further dilation (up to 72.7 +/- 7%) instead of constriction. Similarly, lower doses of arachidonic acid (10(-9) to 10(-6) M) elicited dilations that were diminished at higher doses. These reduced responses were, however, reversed to substantial dilation by SQ-29548. The nitric oxide (NO) synthase blocker, N omega-nitro-L-arginine (L-NNA, 10(-4) M), significantly reduced the dilation to ACh (from 30.6 +/- 5.5 to 5.4 +/- 1.4% at 10(-6) M ACh). In contrast, L-NNA did not affect dilation to SNP. Thus ACh elicits the release of both NO and PGH2 from the venular endothelium.

This article has been cited by other articles:

				E. Toth, A. Racz, J. Toth, P. M. Kaminski, M. S. Wolin, Z. Bagi, and A. Koller Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, reduced NO, and enhanced PGH2/TXA2 mediation Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3096 - H3104. [Abstract] [Full Text] [PDF]

				V. M. Dupouy, P. J. Ferre, E. Uro-Coste, and H. P. Lefebvre Time course of COX-1 and COX-2 expression during ischemia-reperfusion in rat skeletal muscle J Appl Physiol, January 1, 2006; 100(1): 233 - 239. [Abstract] [Full Text] [PDF]

				R. L. Hester and L. W. Hammer Venular-arteriolar communication in the regulation of blood flow Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1280 - R1285. [Abstract] [Full Text] [PDF]

				W. G. Schrage, C. R. Woodman, and M. H. Laughlin Mechanisms of flow and ACh-induced dilation in rat soleus arterioles are altered by hindlimb unweighting J Appl Physiol, March 1, 2002; 92(3): 901 - 911. [Abstract] [Full Text] [PDF]

				L. W. Hammer, A. L. Ligon, and R. L. Hester ATP-mediated release of arachidonic acid metabolites from venular endothelium causes arteriolar dilation Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2616 - H2622. [Abstract] [Full Text] [PDF]

				A. Koller, R. Mizuno, and G. Kaley Flow reduces the amplitude and increases the frequency of lymphatic vasomotion: role of endothelial prostanoids Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1999; 277(6): R1683 - R1689. [Abstract] [Full Text] [PDF]

				A. Koller, G. Dornyei, and G. Kaley Flow-induced responses in skeletal muscle venules: modulation by nitric oxide and prostaglandins Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H831 - H836. [Abstract] [Full Text] [PDF]

				R. Mizuno, A. Koller, and G. Kaley Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostaglandins Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R790 - R796. [Abstract] [Full Text] [PDF]